Myriad Genetics to Present at Cowen Health Care Conference on March 18, 2008
SALT LAKE CITY, UT, Mar 06, 2008 (MARKET WIRE via COMTEX News Network) -- Myriad Genetics, Inc. (NASDAQ: MYGN), announced today that Adrian
Hobden, Ph.D., President of Myriad Pharmaceuticals, Inc., is
scheduled to present an overview of the Company at the 28th Annual
Cowen Health Care Conference, at 10:15 a.m. on March 18, at the
Boston Marriott Copley Place in Boston, Massachusetts.
A live audio webcast of this presentation will be available online
and can be accessed through a link on Myriad's home page at
www.myriad.com.
Myriad Genetics, Inc. is a biopharmaceutical company focused on the
development of novel healthcare products. The Company develops and
markets predictive medicine products, and is developing and intends to
market therapeutic products. Myriad's news and other information are
available on the Company's Web site at www.myriad.com.
Contact:
William A. Hockett
EVP, Corporate Communications
(801) 584-3600
Email: Email Contact
www.myriad.com
SOURCE: Myriad Genetics
http://www2.marketwire.com/mw/emailprcntct?id=2D396EE4851515E0
http://www.myriad.com
|
